What is Vivo Bio Tech Ltd (511509) share price return in the past 10 years?

Vivo Bio Tech Ltd share price has declined -5% annually (CAGR) over the past ten years.

What is the share price of Vivo Bio Tech Ltd (511509)?

Company share prices are keep on changing according to the market conditions. The current trading price of Vivo Bio Tech Ltd (511509) on 04-Jun-2026 16:59:59 at 16:59 is 24.04.

What is the P/E ratio of Vivo Bio Tech?

The latest standalone P/E ratio of Vivo Bio Tech as of 04-Jun-2026 is 0.00.

What is the P/B ratio of Vivo Bio Tech Ltd (511509)?

The latest standalone P/B ratio of Vivo Bio Tech Ltd (511509) as of 04-Jun-2026 is 0.55.

What is the 52-week high and low of Vivo Bio Tech Ltd (511509)?

The 52-week high of Vivo Bio Tech Ltd (511509) is Rs. 43.35 and the 52-week low is Rs. 20.35.

Vivo Bio Tech Ltd (511509) Share Analysis – Quality, Pipeline & Valuation Zone & DeciZen Rating

Name: Vivo Bio Tech Ltd (511509)
Brand: Vivo Bio Tech

Key Metrics

Valuation Multiples

Market Cap

₹53 Cr.

Current Price

₹24

52-Week Low / High

₹20 / 43

TTM EPS

₹-0.9

TTM Sales

₹52.6 Cr.

Book Value per Share

₹43.6

P/E Ratio

0.00

Lower than its 5-year historical median

Industry PE

46.5

Price to Book (P/B)

0.55

Lower than its 5-year historical median

Price to Sales (P/S)

1.01

Lower than its 5-year historical median

EV/EBITDA

5.35

In line with its 5-year historical median

Dividend Yield

0.00%

Profitability Efficiency

Return on Equity (ROE)

12.13%

Outperforms industry median

Return on Capital Employed (ROCE)

13.06%

Outperforms industry median

Return on Assets (ROA)

5.48%

Operating Profit Margin

44.7%

Net Profit Margin

16.22%

Gross Profit Margin

38.8%

Growth Momentum
1-yr vs 3-yr growth

Sales Growth (1 Year)

Improving versus 3-year growth rate

3.99%

Operating Profit Growth (1 Year)

Slowing versus 3-year growth rate

-1.93%

Net Profit Growth (1 Year)

Improving versus 3-year growth rate

200.4%

Asset Quality

Promoter Holding

35.43%

Pledged shares (%) of Promoter's holding (%)

0.00%

Reserves

₹75 Cr.

Equity

₹22.2 Cr.

Face Value

₹10

All Time Low / High

₹1.10 / 115.10

Vivo Bio Tech stock performance

Key Ratios

Check Before You Invest

M-Cap below 100cr DeciZen not available

Q.1 Is Vivo Bio Tech Ltd a good quality company?

Vivo Bio Tech Ltd is a quality company, based on a multi-year financial track record.

This assessment is based on company’s performance on Revenue growth, ROCE, Equity and Assets, key margin ratios, cash conversion cycle, and debt to cash flow from operations and how it compares with its long term averages.

We have analysed the performance of the company on the following:

How has it performed on generating Profits?
By checking its Revenue growth, Gross, Operating and Net Margins compared to its last 5-year median.
How efficiently has it utilized Capital?
By checking its ROCE, ROA, ROE and its Cash Conversion Cycle.
How is it managing its Debt?
By checking its Debt to Equity and Cash Flow from Operations.

How does Vivo Bio Tech Ltd performance compare with that of its Peers?

Q.1 Revenue growth of Vivo Bio Tech Ltd vs industry peers?

Vivo Bio Tech Ltd revenue CAGR is -3.35%, compared to the industry median CAGR of 5.35%, indicating slower growth and losing its market share.

Q.1 Promoter shareholding and pledge status of Vivo Bio Tech Ltd?

Promoters hold 35.43% of the Vivo Bio Tech Ltd, with 0.00% of their stake pledged, indicating no pledge risk.

Q.1 Stock return of Vivo Bio Tech Ltd over the last decade?

Over the last 9 year(s), the stock has delivered a CAGR of -4.2% based on the current price.

10 Year X-Ray : Login to view analysis.

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	TTM
ROCE % ⓘ	6%	12.4%	15.2%	9.6%	14.2%	19.5%	9.6%	11.3%	10.2%	13.1%	-
Value Creation Index ⓘ	-0.6	-0.1	0.1	-0.3	0.0	0.4	-0.3	-0.2	-0.3	-0.1	-
Growth Parameters ⓘ
Sales ⓘ	28.6	34.1	47	55.8	55.4	51.8	51.4	51.6	44.9	46.7	53
Sales YoY Gr.	-	19.4%	37.7%	18.8%	-0.9%	-6.5%	-0.8%	0.5%	-13.1%	4%	-
Adj EPS ⓘ	1	2.7	3.2	1.9	3.5	4.2	1.6	1.8	1.7	2.5	-0.9
YoY Gr.	-	173.5%	19%	-41.4%	85.6%	21.6%	-62.3%	11.3%	-4%	48.8%	-
BVPS (₹) ⓘ	10.7	13.5	17.5	21.8	25.6	30.6	32.3	34.5	36.3	41.2	43.6
Adj Net Profit ⓘ	0.9	2.5	3.1	2.3	4.5	5.7	2.3	2.6	2.5	4.3	-2
Cash Flow from Ops. ⓘ	8.7	-5.7	11.1	-0.8	7.7	14.1	16.4	14.7	15.8	11.8	-
Debt/CF from Ops. ⓘ	1.9	-4.8	2.3	-27.5	2.9	2	4	4.1	4.5	4.4	-

CAGR ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	5.6%	-3.4%	-3.2%	4%
Adj EPS ⓘ	11.1%	-6.1%	16.8%	48.8%
BVPSⓘ	16.1%	10%	8.5%	13.5%
Share Price	-5%	-20%	-7.1%	-36.8%

Key Financial Parameters ⓘ

	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	TTM
Return on Equity % ⓘ	9.5	22.1	19.7	9.9	14.8	15	5.1	5.3	4.8	6.6	-2.1
Op. Profit Mgn % ⓘ	13	22.4	23.2	17.2	22.6	34.4	31.5	42.3	47.4	44.7	40.4
Net Profit Mgn % ⓘ	3.2	7.3	6.7	4.1	8.1	11	4.4	5.1	5.7	9.3	-3.7
Debt to Equity ⓘ	1.7	2.2	1.5	0.8	0.7	0.7	1.4	1.2	1.3	0.7	0.5
Working Cap Days ⓘ	138	155	165	158	170	191	188	204	320	348	155
Cash Conv. Cycle ⓘ	-45	-11	37	53	81	118	127	131	152	140	56

Profit And Loss

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Sales	28.58	34.13	47	55.83	55.35	51.78	51.39	51.62	44.88	46.67
Operating Expenses ⓘ +	24.88	26.50	36.12	46.32	42.88	33.97	35.30	29.80	23.63	25.83
Manufacturing Costs	2.55	3.12	3.10	5.07	6.89	5.87	3.77	4.56	4.24	3.60
Material Costs	8.80	8.14	9.57	11.76	8.56	7.21	11.44	6.77	3.85	5.79
Employee Cost	4.34	5.50	7.66	9.58	10	8.57	9.42	13.15	10.13	11.86
Other Costs ⓘ	9.18	9.74	15.80	19.91	17.43	12.32	10.67	5.32	5.41	4.58
Operating Profit ⓘ	3.71	7.63	10.88	9.51	12.47	17.81	16.09	21.82	21.25	20.84
Operating Profit Margin (%)	13.0%	22.4%	23.2%	17.0%	22.5%	34.4%	31.3%	42.3%	47.4%	44.7%
Other Income ⓘ +	0.89	0.40	0.13	0.01	0.05	0.08	0.09	0.04	0.04	4.80
Exceptional Items ⓘ	0	0	0	0	0	0	0	0	0	0
Interest ⓘ	0.47	1.29	2.37	2.64	3.10	3.67	4.27	7.99	7.95	7.55
Depreciation ⓘ	3.35	3.90	4.64	5.06	5.17	5.59	7.44	9.27	9.29	9.02
Profit Before Tax ⓘ	0.78	2.84	4.01	1.83	4.26	8.62	4.47	4.61	4.05	9.08
Tax ⓘ	-0.13	0.33	0.88	-0.42	-0.19	2.94	2.27	1.97	1.53	1.51
Profit After Tax	0.91	2.50	3.12	2.25	4.44	5.68	2.20	2.63	2.52	7.57
PAT Margin (%)	3.2%	7.3%	6.6%	4.0%	8.0%	11.0%	4.3%	5.1%	5.6%	16.2%
Adjusted EPS (₹)	1.0	2.7	3.2	1.8	3.5	4.2	1.5	1.8	1.7	4.4
Dividend Payout Ratio (%)	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%

Valuation of Vivo Bio Tech - Standalone

YTD 1Y 3Y 5Y 10Y Max

Analyst's Notes

No data found!

Balance Sheet

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Equity and Liabilities
Shareholders Fund +	10.08	12.60	17.23	26.98	33.04	41.12	46.46	51.87	54.40	70.92
Share Capital ⓘ	9.35	9.35	9.85	12.35	12.89	13.42	14.26	14.90	14.90	17.16
Reserves ⓘ	0.73	3.25	7.38	14.63	20.15	27.70	32.19	36.97	39.49	53.75
Debt +	16.91	27.06	25.11	21.67	22.09	24.35	58.80	52.45	62.24	44.07
Long Term Debt	14.11	20.93	13.90	8.90	7.41	12.42	47.88	40.87	39.56	32.71
Short Term Debt	2.81	6.12	11.21	12.77	14.67	11.92	10.92	11.59	22.68	11.36
Minority Interest	0	0	0	0	0	0	0	0	0	0
Trade Payables	8.75	5.40	7.98	3.87	3.91	1.39	2.32	0.94	1.06	0.98
Others Liabilities ⓘ	9.93	6.08	9.20	2.56	0.84	10.46	12.73	15.54	17.10	25.32
Total Liabilities ⓘ	45.67	51.14	59.53	55.08	59.87	77.31	120.30	120.81	134.80	141.29
Fixed Assets
Net Fixed Assets ⓘ +	23.35	28.37	27.47	29.82	31.63	48.69	91.81	85.51	77.01	84.88
Gross Block	34.95	43.88	47.61	55.02	62	84.65	135.16	138.12	138.70	155.53
Accumulated Depreciation	11.60	15.51	20.14	25.20	30.37	35.97	43.35	52.61	61.69	70.65
CWIP ⓘ	0.04	2.96	3.94	0.07	0.15	0.32	0.87	1.90	9.21	12.84
Investments ⓘ	0.03	0.03	0.03	0.03	0.04	0.04	0.04	0.04	0.04	0.04
Inventories	4.08	4.56	7.59	8.24	10.58	13.28	9.81	7.97	8.77	7.79
Trade Receivables	3.82	7.67	11.78	8.41	10.48	7.29	12.02	12.38	11.37	11.21
Cash Equivalents	11.85	1.18	4.15	0.53	0.99	1.10	1.47	0.99	1.32	1.21
Others Assets ⓘ	2.50	6.36	4.58	7.99	6	6.59	4.28	12.01	27.08	23.32
Total Assets ⓘ	45.67	51.14	59.53	55.08	59.87	77.31	120.30	120.81	134.80	141.29

Cash Flow

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Cash Flow From Operating Activity ⓘ +	8.73	-5.65	11.11	-0.79	7.72	14.10	16.43	14.73	15.83	11.83
PBT ⓘ	0.78	2.85	4.01	1.83	4.26	8.62	4.47	4.61	4.05	9.08
Adjustment ⓘ	3.82	5.19	7.02	7.70	8.27	9.12	11.43	16.92	17.07	11.91
Changes in Working Capital ⓘ	4.47	-12.07	3.34	-8.1	-1.9	2.82	3.98	-3.46	-2.24	-5.04
Tax Paid ⓘ	0.13	-0.33	-0.88	0.42	0.19	-2.94	-2.27	-1.97	-1.53	-2.08
Cash Flow From Investing Activity ⓘ +	-7.12	-11.84	-4.72	-3.53	-7.08	-22.82	-51.11	-4	-7.95	-15.84
Capex	-7.11	-11.84	-4.72	-3.53	-7.07	-22.82	-51.11	-4	-7.95	-15.84
Net Investments	-0.01	0	0	0	-0.01	0	0	0	0	0
Others ⓘ	0	0	0	0	0	0	0	0	0	0
Cash Flow From Financing Activity ⓘ +	-0.32	6.83	-3.43	0.70	-0.18	8.83	35.04	-11.20	-7.56	3.90
Net Proceeds from Shares ⓘ	0	0	1.50	5.70	1.31	3.82	2.40	2.10	0	16.22
Net Proceeds from Borrowing ⓘ	-0.32	6.83	-4.93	-5	-1.49	5.01	35.45	-7.01	-1.30	-6.85
Interest Paid ⓘ	0	0	0	0	0	0	-2.81	-6.28	-6.25	-5.47
Dividend Paid ⓘ	0	0	0	0	0	0	0	0	0	0
Others ⓘ	0	0	0	0	0	0	-0	0	0	0
Net Cash Flow ⓘ	1.29	-10.67	2.96	-3.62	0.46	0.11	0.37	-0.47	0.32	-0.11

Financial Ratio

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Ratios
ROE (%)	9.48	22.14	20.98	10.21	14.85	15.35	5.06	5.41	4.78	12.13
ROCE (%)	5.96	12.39	15.17	9.58	14.15	19.47	9.55	11.26	10.15	13.06
Asset Turnover Ratio	0.66	0.71	0.85	0.97	0.96	0.75	0.52	0.43	0.35	0.34
PAT to CFO Conversion(x)	9.59	-2.26	3.56	-0.35	1.74	2.48	7.47	5.6	6.28	1.56
Working Capital Days
Receivable Days	51.90	61.40	75.50	66	62.30	62.70	68.60	86.30	96.60	88.30
Inventory Days	56	46.20	47.20	51.70	62	84.10	82	62.90	68.10	64.80
Payable Days	323.60	317	255.20	183.90	166	134.30	59.10	87.80	94.90	64.30

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged ^*

0.00

* Pledged shares as % of Promoter's holding (%)

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Vivo Bio Tech Ltd FAQs

The current trading price of Vivo Bio Tech on 04-Jun-2026 16:59 is ₹24.04.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 03-Jun-2026 the market cap of Vivo Bio Tech stood at ₹53.35 Cr

The latest P/E ratio of Vivo Bio Tech as of 03-Jun-2026 is 0.00.

The latest P/B ratio of Vivo Bio Tech as of 03-Jun-2026 is 0.55.

The 52-week high of Vivo Bio Tech is ₹43.35 and the 52-week low is ₹20.35.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Vivo Bio Tech is ₹52.57 ( Cr.) .

Past 10 year's financial track record analysis by Moneyworks4me indicates that Vivo Bio Tech Ltd is a average quality company.

The key valuation ratios of Vivo Bio Tech Ltd's currently when compared to its past seem to suggest it is in the Undervalued zone.

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Vivo Bio Tech Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

About Vivo Bio Tech Ltd

Vivo Bio Tech was incorporated on February 12, 1987 as Golden Growth Fund, Hyderabad-based Vivo Bio Tech (VBTL) is a contract research company engaged in biotechnology and pharma drug discovery activities. The company was converted into a public limited company from Jun. 19, 1992. VBTL provides services ranging from insilico design, wet lab contract research, preclinical research and clinical studies spanning the entire drug discovery value chain.

It is a full service CRO offering drug development & discovery services to pharmaceutical & biotech companies world-wide in accordance with OECD, AAALAC & IND guidelines. The company offers services in the areas of custom research, In-vitro and In-vivo toxicity studies, pharmacological investigations, pharmacokinetics & toxicokinetic studies etc. Our experienced & talented scientists offer advice on defining drug development paths tailored to specific molecules. Tailored and dedicated to our clients, we distinguish your development plan is as superlative as the products you bring to our testing facilities.

The Custom Research Services group at Vivo Bio Tech offers a complete line of protein services, including gene synthesis, cloning, expression and purification of recombinant proteins and monoclonal antibodies. Our scientists will team up with you to develop solution for the most difficult to deal products including purification of untagged & poorly expressed proteins.

In-vitro Services offers solutions for pharmacologic, toxicological & bioanalytical investigations in drug discovery & development. Critical investigations like bacterial reverse mutation assays, chromosomal aberration, and micronucleus are specialty services by our scientists.

Vivo Bio Tech has obtained permission from the Govt. of India for developing Biotech Sector Specific 'Special Economic Zone' at its site (39 acres) in Pregnapur, Gajwel Mandal, Medak District, Andhra Pradesh.The Vivo Bio Tech SEZ is located adjacent to Karimnagar highway road (approx 16 km from ICICI Knowledge Park and SP Biotech Park). The site is approximately 53km from Secunderabad Railway Station and around 90km from the new airport (Shamshabad).

Vivo Bio Tech Ltd (511509)

Vivo Bio Tech Ltd (511509)

Vivo Bio Tech stock performance

Check Before You Invest

M-Cap below 100cr DeciZen not available

10 Year X-Ray : Login to view analysis.

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Value Creation ⓘ

Growth Parameters ⓘ

CAGR ⓘ

Key Financial Parameters ⓘ

Profit And Loss

Valuation of Vivo Bio Tech - Standalone

Price Calculator

Price Chart

Price to Earnings

Price to Sales

Price to Book

EV to EBITDA

Dividend History

Analyst's Notes

Balance Sheet

Equity and Liabilities

Fixed Assets

Cash Flow

Financial Ratio

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Vivo Bio Tech Ltd FAQs

About Vivo Bio Tech Ltd

About MoneyWorks4Me

Our Vision

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045
Compliance officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com Telephone: +91 98609 19463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com Telephone: +91 91758 99463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

Vivo Bio Tech Ltd (511509)

Vivo Bio Tech Ltd (511509)

Vivo Bio Tech stock performance

Check Before You Invest

M-Cap below 100cr DeciZen not available

10 Year X-Ray : Login to view analysis.

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Value Creation ⓘ

Growth Parameters ⓘ

CAGR ⓘ

Key Financial Parameters ⓘ

Profit And Loss

Valuation of Vivo Bio Tech - Standalone

Price Calculator

Price Chart

Price to Earnings

Price to Sales

Price to Book

EV to EBITDA

Dividend History

Price Calculator

Price Chart

Price to Earnings

Enterprise Value to EBIT

Price to Book-Value

Price to Sales

Dividend History

Analyst's Notes

Balance Sheet

Equity and Liabilities

Fixed Assets

Cash Flow

Financial Ratio

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Vivo Bio Tech Ltd FAQs

What is the share price of Vivo Bio Tech?

What is the market cap of Vivo Bio Tech?

What is the P/E ratio of Vivo Bio Tech?

What is the P/B ratio of Vivo Bio Tech?

What is the 52-week high and low of Vivo Bio Tech?

What is the TTM revenue of Vivo Bio Tech?

Is Vivo Bio Tech Ltd a good quality company?

Is Vivo Bio Tech Ltd undervalued or overvalued?

Is Vivo Bio Tech Ltd a good buy now?

About Vivo Bio Tech Ltd

About MoneyWorks4Me

Our Vision

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.